- Cellipont Bioservices has completed its 100th GMP batch release at its cell therapy manufacturing facility in The Woodlands, Texas, approximately one year after beginning GMP operations in June 2025.
- The company said the milestone reflects its operational capabilities and continued support for clients through process development, analytical development, and clinical and commercial manufacturing.
Cellipont Bioservices, a cell therapy CDMO, has announced the successful release of its 100th GMP batch at its manufacturing facility in The Woodlands, Texas. The milestone comes approximately one year after the company began GMP manufacturing operations at the site in June 2025 and highlights the expansion of its contract manufacturing activities.
According to the company, reaching 100 GMP batch releases within a year reflects its operational infrastructure, increasing client demand, and the work of its cross-functional teams. The milestone was supported by teams across Manufacturing, Quality, Supply Chain, Manufacturing Science and Technology, Facilities, Validation, and other operational functions responsible for delivering GMP batches while maintaining quality standards and client timelines.
“We are incredibly proud of the Cellipont team and what they have accomplished in such a short period of time. Reaching our 100th GMP batch release approximately one year after beginning manufacturing operations is an impressive achievement and a testament to the expertise, collaboration, and commitment our employees bring to every client program.”
Darren Head, CEO of Cellipont Bioservices
The company said each GMP batch represents its responsibility to support client programs developing cell therapies. According to Cellipont, the milestone reflects the trust placed in the company by its clients as it continues to expand its manufacturing experience.
Cellipont said it will continue to build its capabilities to support cell therapy developers across process and analytical development, as well as clinical and commercial manufacturing.
